{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:12:13Z","timestamp":1762956733413,"version":"build-2065373602"},"reference-count":59,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23 AR075070","L30 AR070514"],"award-info":[{"award-number":["K23 AR075070","L30 AR070514"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000940","name":"Arthritis Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000940","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.berh.2021.101724","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T06:10:25Z","timestamp":1637129425000},"page":"101724","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Review: Outcome measures in calcium pyrophosphate deposition"],"prefix":"10.1016","volume":"35","author":[{"given":"Ken","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara K.","family":"Tedeschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.berh.2021.101724_bib1","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/art.1780300811","article-title":"The prevalence of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study","volume":"30","author":"Felson","year":"1987","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.berh.2021.101724_bib2","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/ard.62.6.513","article-title":"UK community prevalence of knee chondrocalcinosis: evidence that correlation with osteoarthritis is through a shared association with osteophyte","volume":"62","author":"Neame","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.berh.2021.101724_bib3","first-page":"819","article-title":"Prevalence of musculoskeletal conditions in an Italian population sample: results of a regional community-based study. I. The MAPPING study","volume":"23","author":"Salaffi","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2021.101724_bib4","first-page":"142","article-title":"Chondrocalcinosis articularis Section L Clinical and radiological study","volume":"22","author":"Zitnan","year":"1963","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2021.101724_bib5","doi-asserted-by":"crossref","first-page":"711","DOI":"10.7326\/0003-4819-56-5-711","article-title":"The significance of calcium pyrophosphate crystals in the synovial fluid of arthritic patients: : the \u201cpseudogout syndrome\u201d. 1. Clinical Aspects","volume":"56","author":"McCarty","year":"1962","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.berh.2021.101724_bib6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11926-019-0847-4","article-title":"Issues in CPPD nomenclature and classification","volume":"21","author":"Tedeschi","year":"2019","journal-title":"Curr Rheumatol Rep"},{"issue":"4","key":"10.1016\/j.berh.2021.101724_bib7","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/ard.2010.139105","article-title":"European League against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis","volume":"70","author":"Zhang","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.berh.2021.101724_bib8","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.3899\/jrheum.161057","article-title":"Definition and reliability assessment of elementary ultrasonographic findings in calcium pyrophosphate deposition disease: a study by the OMERACT calcium pyrophosphate deposition disease ultrasound Subtask Force","volume":"44","author":"Filippou","year":"2017","journal-title":"J\u00a0Rheumatol"},{"issue":"8","key":"10.1016\/j.berh.2021.101724_bib9","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1136\/annrheumdis-2017-212542","volume":"77","author":"Filippou","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.berh.2021.101724_bib10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1136\/annrheumdis-2020-217998","article-title":"Criterion validity of ultrasound in the identification of calcium pyrophosphate crystal deposits at the knee: an OMERACT ultrasound study","volume":"80","author":"Filippou","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.berh.2021.101724_bib11","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3899\/jrheum.181097","article-title":"Core domain set selection according to OMERACT filter 2.1: the OMERACT methodology","volume":"46","author":"Maxwell","year":"2019","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2021.101724_bib12","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.semarthrit.2020.05.015","article-title":"Outcome domains reported in calcium pyrophosphate deposition studies: a scoping review by the OMERACT CPPD working group","volume":"50","author":"Cai","year":"2020","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.berh.2021.101724_bib13","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.semarthrit.2020.09.021","article-title":"Outcome domains reported by patients, caregivers, healthcare professionals and stakeholders for calcium pyrophosphate deposition (CPPD): a content analysis based on semi-structured qualitative interviews from the OMERACT CPPD working group","volume":"51","author":"Fuller","year":"2021","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.berh.2021.101724_bib14","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.semarthrit.2021.04.010","article-title":"Experience and impact of crystal pyrophosphate deposition (CPPD) from a patient and caregiver perspective: a qualitative exploration from the OMERACT CPPD working group","volume":"51","author":"Fuller","year":"2021","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.berh.2021.101724_bib15","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.semarthrit.2021.04.019","article-title":"Towards development of core domain sets for short term and long term studies of calcium pyrophosphate crystal deposition (CPPD) disease: a framework paper by the OMERACT CPPD working group","volume":"51","author":"Cai","year":"2021","journal-title":"Semin Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.berh.2021.101724_bib16","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/acr.21952","article-title":"Evidence of a systemic predisposition to chondrocalcinosis and association between chondrocalcinosis and osteoarthritis at distant joints: a cross-sectional study","volume":"65","author":"Abhishek","year":"2013","journal-title":"Arthritis Care Res"},{"issue":"8","key":"10.1016\/j.berh.2021.101724_bib17","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3899\/jrheum.181096","article-title":"OMERACT filter 2.1: elaboration of the conceptual framework for outcome measurement in health intervention studies","volume":"46","author":"Boers","year":"2019","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2021.101724_bib18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7326\/0003-4819-87-2-240","article-title":"Calcium pyrophosphate dihydrate crystal deposition disease: nomenclature and diagnostic criteria","volume":"87","author":"McCarty","year":"1977","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.berh.2021.101724_bib19","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.joca.2021.01.007","article-title":"The diagnostic value of conventional radiography and musculoskeletal ultrasonography in calcium pyrophosphate deposition disease: a systematic literature review and meta-analysis. Osteoarthritis and cartilage\/OARS","volume":"29","author":"Cipolletta","year":"2021","journal-title":"Osteoarthritis Research Society"},{"issue":"4","key":"10.1016\/j.berh.2021.101724_bib20","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/art.41569","article-title":"Can dual-energy computed tomography Be used to identify early calcium crystal deposition in the knees of patients with calcium pyrophosphate deposition?","volume":"73","author":"Budzik","year":"2021","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.berh.2021.101724_bib21","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.joca.2019.05.007","article-title":"Dual-energy computed tomography in calcium pyrophosphate deposition: initial clinical experience. Osteoarthritis and cartilage\/OARS","volume":"27","author":"Pascart","year":"2019","journal-title":"Osteoarthritis Research Society"},{"issue":"4","key":"10.1016\/j.berh.2021.101724_bib22","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/rheumatology\/kez431","article-title":"A prospective study of dual-energy CT scanning, US and X-ray in acute calcium pyrophosphate crystal arthritis","volume":"59","author":"Tedeschi","year":"2020","journal-title":"Rheumatology"},{"issue":"7","key":"10.1016\/j.berh.2021.101724_bib23","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/art.40848","article-title":"Clinical utility of multi-energy spectral photon-counting computed tomography in crystal arthritis","volume":"71","author":"Stamp","year":"2019","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.berh.2021.101724_bib24","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1007\/s10067-020-05516-3","article-title":"A critical review of the available evidence on the diagnosis and clinical features of CPPD: do we really need imaging?","volume":"40","author":"Filippou","year":"2021","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.berh.2021.101724_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11926-020-0890-1","article-title":"Utility of ultrasound and dual energy CT in crystal disease diagnosis and management","volume":"22","author":"Filippou","year":"2020","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"10.1016\/j.berh.2021.101724_bib26","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.joca.2016.01.136","article-title":"Ultrasound in the diagnosis of calcium pyrophosphate dihydrate deposition disease. A systematic literature review and a meta-analysis. Osteoarthritis and cartilage\/OARS","volume":"24","author":"Filippou","year":"2016","journal-title":"Osteoarthritis Research Society"},{"issue":"5","key":"10.1016\/j.berh.2021.101724_bib27","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.joca.2018.11.013","article-title":"Diagnostic value of ultrasound in calcium pyrophosphate deposition disease of the knee joint. Osteoarthritis and cartilage\/OARS","volume":"27","author":"Lee","year":"2019","journal-title":"Osteoarthritis Research Society"},{"issue":"1","key":"10.1016\/j.berh.2021.101724_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2015-000118","article-title":"Diagnostic value of ultrasound in calcium pyrophosphate deposition disease: a systematic review and meta-analysis","volume":"1","author":"Gamon","year":"2015","journal-title":"RMD Open"},{"issue":"1","key":"10.1016\/j.berh.2021.101724_bib29","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13018-018-0787-0","article-title":"Detection of calcium pyrophosphate dihydrate crystals in knee meniscus by dual-energy computed tomography","volume":"13","author":"Tanikawa","year":"2018","journal-title":"J\u00a0Orthop Surg Res"},{"issue":"6","key":"10.1016\/j.berh.2021.101724_bib30","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/ard.61.6.493","article-title":"The value of synovial fluid assays in the diagnosis of joint disease: a literature survey","volume":"61","author":"Swan","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.berh.2021.101724_bib31","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s10067-016-3461-0","article-title":"Crystal identification of synovial fluid aspiration by polarized light microscopy. An online test suggesting that our traditional rheumatologic competence needs renewed attention and training","volume":"36","author":"Berendsen","year":"2017","journal-title":"Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2021.101724_bib32","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/acr.22754","article-title":"Development of a dual-energy computed tomography scoring system for measurement of urate deposition in gout","volume":"68","author":"Bayat","year":"2016","journal-title":"Arthritis Care Res"},{"issue":"9","key":"10.1016\/j.berh.2021.101724_bib33","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0003-4967(24)43379-7","article-title":"Radiographic scoring methods as outcome measures in rheumatoid arthritis: properties and advantages","volume":"60","author":"Boini","year":"2001","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2021.101724_bib34","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-001144","article-title":"Assessing the sensitivity to change of the OMERACT ultrasound structural gout lesions during urate-lowering therapy","volume":"6","author":"Christiansen","year":"2020","journal-title":"RMD Open"},{"issue":"6","key":"10.1016\/j.berh.2021.101724_bib35","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/art.22891","article-title":"Validation of a radiographic damage index in chronic gout","volume":"57","author":"Dalbeth","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.berh.2021.101724_bib36","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1093\/rheumatology\/kev112","article-title":"International Consensus for ultrasound lesions in gout: results of Delphi process and web-reliability exercise","volume":"54","author":"Gutierrez","year":"2015","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.berh.2021.101724_bib37","first-page":"198","article-title":"The OMERACT filter for outcome measures in Rheumatology","volume":"25","author":"Boers","year":"1998","journal-title":"J\u00a0Rheumatol"},{"issue":"26","key":"10.1016\/j.berh.2021.101724_bib38","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1056\/NEJMra1511117","article-title":"Calcium pyrophosphate deposition disease","volume":"374","author":"Rosenthal","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.berh.2021.101724_bib39","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/ard.2010.139360","article-title":"EULAR recommendations for calcium pyrophosphate deposition. Part II: management","volume":"70","author":"Zhang","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.berh.2021.101724_bib40","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.3899\/jrheum.080506","article-title":"Evaluation of an instrument assessing influence of Gout on health-related quality of life","volume":"35","author":"Hirsch","year":"2008","journal-title":"J\u00a0Rheumatol"},{"issue":"12","key":"10.1016\/j.berh.2021.101724_bib41","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1136\/annrheumdis-2014-205671","article-title":"Development of a patient-reported outcome measure of tophus burden: the Tophus Impact Questionnaire (TIQ-20)","volume":"74","author":"Aati","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.berh.2021.101724_bib42","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/rheumatology\/kez064","article-title":"Development and validation of a patient-reported gout attack intensity score for use in gout clinical studies","volume":"58","author":"Janssen","year":"2019","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.berh.2021.101724_bib43","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1136\/ard.2007.084459","volume":"68","author":"Wells","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"5 Suppl 39","key":"10.1016\/j.berh.2021.101724_bib44","first-page":"S100","article-title":"The simplified disease activity index (SDAI) and the clinical disease activity index (CDAI): a review of their usefulness and validity in rheumatoid arthritis","volume":"23","author":"Aletaha","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2021.101724_bib45","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/art.1780380612","article-title":"A\u00a0self-administered rheumatoid arthritis disease activity index (RADAI) for epidemiologic research","volume":"6","author":"Stucki","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.berh.2021.101724_bib46","first-page":"1833","article-title":"Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee","volume":"15","author":"Bellamy","year":"1988","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2021.101724_bib47","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1477-7525-1-17","article-title":"Knee injury and Osteoarthritis Outcome Score (KOOS) - validation and comparison to the WOMAC in total knee replacement","volume":"1","author":"Roos","year":"2003","journal-title":"Health Qual Life Outcome"},{"issue":"6","key":"10.1016\/j.berh.2021.101724_bib48","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1136\/ard.2007.079970","article-title":"A\u00a0modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout","volume":"67","author":"Taylor","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.berh.2021.101724_bib49","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/ard.2010.139899","article-title":"Methods of tophus assessment in clinical trials of chronic gout: a systematic literature review and pictorial reference guide","volume":"70","author":"Dalbeth","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.berh.2021.101724_bib50","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/art.41186","article-title":"Chondrocalcinosis of the knee and the risk of osteoarthritis progression: data from the knee and hip osteoarthritis long-term assessment cohort","volume":"72","author":"Latourte","year":"2020","journal-title":"Arthritis & rheumatology."},{"issue":"6","key":"10.1016\/j.berh.2021.101724_bib51","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/art.21903","article-title":"Lack of association between chondrocalcinosis and increased risk of cartilage loss in knees with osteoarthritis: results of two prospective longitudinal magnetic resonance imaging studies","volume":"54","author":"Neogi","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2021.101724_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/acr2.11260","article-title":"The association of diuretics and proton pump inhibitors with chondrocalcinosis","author":"Felson","year":"2021","journal-title":"ACR Open Rheumatology"},{"issue":"4","key":"10.1016\/j.berh.2021.101724_bib53","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/RHU.0000000000000251","article-title":"Validation of administrative codes for calcium pyrophosphate deposition: a Veterans Administration study","volume":"21","author":"Bartels","year":"2015","journal-title":"J\u00a0Clin Rheumatol : practical reports on rheumatic & musculoskeletal diseases"},{"issue":"9","key":"10.1016\/j.berh.2021.101724_bib54","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/acr.23160","article-title":"Calcium pyrophosphate deposition disease and associated medical comorbidities: a national cross-sectional study of US veterans","volume":"69","author":"Kleiber Balderrama","year":"2017","journal-title":"Arthritis Care Res"},{"issue":"8","key":"10.1016\/j.berh.2021.101724_bib55","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3899\/jrheum.190778","article-title":"Acute calcium pyrophosphate crystal arthritis flare rate and risk factors for recurrence","volume":"47","author":"Yates","year":"2020","journal-title":"J\u00a0Rheumatol"},{"issue":"11","key":"10.1016\/j.berh.2021.101724_bib56","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1093\/rheumatology\/kes204","article-title":"Risk factors for pseudogout in the general population","volume":"51","author":"Rho","year":"2012","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.berh.2021.101724_bib57","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006177","article-title":"Incident acute pseudogout and prior bisphosphonate use: matched case-control study in the UK-Clinical Practice Research Datalink","volume":"96","author":"Roddy","year":"2017","journal-title":"Medicine (Baltim)"},{"year":"2020","series-title":"Classifying pseudogout using machine learning approaches with electronic health record data","author":"Tedeschi","key":"10.1016\/j.berh.2021.101724_bib58"},{"key":"10.1016\/j.berh.2021.101724_bib59","article-title":"Identifying potential classification criteria for calcium pyrophosphate deposition disease (CPPD): item generation and item reduction","author":"Tedeschi","year":"2021","journal-title":"Arthritis Care Res\u202f: the official journal of the Arthritis Health Professions Association."}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694221000668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694221000668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:22:57Z","timestamp":1761499377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694221000668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1521694221000668"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2021.101724","relation":{},"ISSN":["1521-6942"],"issn-type":[{"type":"print","value":"1521-6942"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review: Outcome measures in calcium pyrophosphate deposition","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2021.101724","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101724"}}